Osmanbeyoglu, Hatice U. http://orcid.org/0000-0002-3175-1777
Shimizu, Fumiko http://orcid.org/0000-0003-4107-2871
Rynne-Vidal, Angela http://orcid.org/0000-0002-6316-530X
Alonso-Curbelo, Direna
Chen, Hsuan-An http://orcid.org/0000-0002-8979-3670
Wen, Hannah Y.
Yeung, Tsz-Lun
Jelinic, Petar
Razavi, Pedram
Lowe, Scott W.
Mok, Samuel C.
Chiosis, Gabriela
Levine, Douglas A. http://orcid.org/0000-0003-1038-8232
Leslie, Christina S. http://orcid.org/0000-0002-4571-5910
Article History
Received: 25 July 2018
Accepted: 2 September 2019
First Online: 25 September 2019
Competing interests
: P.R. reports consulting/advisory board for Novartis and Iinstitutional Rresearch support from Illumina and GRAIL, Inc. The remaining authors declare no competing interests.